Dabigatran or warfarin for extended maintenance therapy of venous thromboembolism

被引：0
|
作者：
Schulman, S. [1 ]
Eriksson, H. [2 ]
Goldhaber, S. Z. [3 ]
Kakkar, A. K. L. [4 ,5 ]
Kearon, C. [6 ]
Kvamme, A. M. [7 ]
Mismetti, P. [8 ]
Schellong, S. [9 ]
Schnee, J. [10 ]
机构：
[1] HHS Gen Hosp, Thrombosis Serv, Hamilton, ON, Canada
[2] Sahlgrenska Univ Hosp Oestra, Dept Med, Gothenburg, Sweden
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA
[4] Thrombosis Res Inst, London SW3 6LR, England
[5] Queen Mary Univ London, London, England
[6] McMaster Univ, Dept Med, Hamilton, ON, Canada
[7] Boehringer Ingelheim GmbH & Co KG, Dept Med, Oslo, Norway
[8] Bellevue Hosp, Dept Vasc Pathol, St Etienne, France
[9] Municipal Hosp Friedrichstadt, Med Div 2, Dresden, Germany
[10] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O-TH-033
引用
收藏
页码：731 / 732
页数：2
相关论文
共 50 条
  • [21] Direct Thrombin Inhibitors for the Treatment of Venous Thromboembolism: Analysis of the Dabigatran versus Warfarin Clinical Trial
    Liem, Timothy K.
    DeLoughery, Thomas G.
    SEMINARS IN VASCULAR SURGERY, 2011, 24 (03) : 157 - 161
  • [22] Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism
    Witt, Daniel M.
    Clark, Nathan P.
    Kaatz, Scott
    Schnurr, Terri
    Ansell, Jack E.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2016, 41 (01) : 187 - 205
  • [23] Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism
    Daniel M. Witt
    Nathan P. Clark
    Scott Kaatz
    Terri Schnurr
    Jack E. Ansell
    Journal of Thrombosis and Thrombolysis, 2016, 41 : 187 - 205
  • [24] Dabigatran etexilate for prevention of venous thromboembolism
    Eikelboom, John E.
    Weitz, Jeffrey I.
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (01) : 2 - 4
  • [25] Predicting warfarin maintenance dose in patients with venous thromboembolism based on the response to a standardized warfarin initiation nomogram
    Lazo-Langner, A.
    Monkman, K.
    Kovacs, M. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (08) : 1276 - 1283
  • [26] Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis
    Alotaibi, G.
    Alsaleh, K.
    Wu, C.
    McMurtry, M. S.
    INTERNATIONAL ANGIOLOGY, 2014, 33 (04) : 301 - 308
  • [27] Dabigatran (Pradaxa) Is Safe for Extended Venous Thromboembolism Prophylaxis After Surgery for Pancreatic Cancer
    Rashid, M. Farzan
    Jackson, Terri L.
    Morgan, Jheanell A.
    Dwyer, Franklin A.
    Schrope, Beth A.
    Chabot, John A.
    Kluger, Michael D.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 23 (06) : 1166 - 1171
  • [28] Dabigatran (Pradaxa) Is Safe for Extended Venous Thromboembolism Prophylaxis After Surgery for Pancreatic Cancer
    M. Farzan Rashid
    Terri L. Jackson
    Jheanell A. Morgan
    Franklin A. Dwyer
    Beth A. Schrope
    John A. Chabot
    Michael D. Kluger
    Journal of Gastrointestinal Surgery, 2019, 23 : 1166 - 1171
  • [29] Dabigatran as an alternative to warfarin in the prevention of thromboembolism in atrial fibrillation
    De Caterina, Raffaele
    Renda, Giulia
    GIORNALE ITALIANO DI CARDIOLOGIA, 2012, 13 (11) : 19S - 27S
  • [30] Aspirin for long term maintenance therapy of venous thromboembolism
    Schellong, Sebastian
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2013, 42 (02) : 83 - 85
12345